SOD2 and skin neoplasm: A study shows that Mn-SOD deficiency (Sod2+/− deletion) increases oxidative stress, AP-1 activation, and cell proliferation after DMBA/TPA treatment, whereas Mn-SOD overexpression inhibits the development of skin tumors by decreasing AP-1 activity [102].